Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s109, 2023. DOI: 10.25251/skin.7.supp.109. Disponível em: https://skin.dermsquared.com/skin/article/view/1982. Acesso em: 19 apr. 2025.